Atea Pharmaceuticals, Inc.
AVIR
$3.08
$0.020.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 454.72M | 482.81M | 502.21M | 541.49M | 578.11M |
| Total Receivables | -- | -- | -- | 1.29M | 5.90M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.63M | 4.09M | 4.16M | 5.98M | 6.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 462.36M | 486.91M | 506.37M | 548.76M | 590.46M |
|
|
|||||
| Total Current Assets | 462.36M | 486.91M | 506.37M | 548.76M | 590.46M |
| Net Property, Plant & Equipment | 2.12M | 2.37M | 2.62M | 2.87M | 3.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 197.00K | 1.68M | 1.40M | 1.40M | 1.40M |
| Total Assets | 464.67M | 490.96M | 510.38M | 553.03M | 594.97M |
|
|
|||||
| Total Accounts Payable | 4.46M | 5.79M | 5.47M | 21.14M | 4.25M |
| Total Accrued Expenses | 13.35M | 18.62M | 20.37M | 19.41M | 27.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 800.00K | 790.00K | 780.00K | 769.00K | 760.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.60M | 25.19M | 26.62M | 41.31M | 32.38M |
|
|
|||||
| Total Current Liabilities | 18.60M | 25.19M | 26.62M | 41.31M | 32.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 842.00K | 1.05M | 1.25M | 1.45M | 1.64M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.36M | 6.20M | 6.05M | 5.90M | 5.76M |
| Total Liabilities | 25.80M | 32.44M | 33.91M | 48.66M | 39.78M |
|
|
|||||
| Common Stock & APIC | 802.85M | 788.56M | 776.28M | 763.56M | 750.82M |
| Retained Earnings | -364.22M | -330.68M | -299.53M | -259.00M | -195.84M |
| Treasury Stock & Other | 233.00K | 641.00K | -280.00K | -181.00K | 207.00K |
| Total Common Equity | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 438.87M | 458.52M | 476.47M | 504.37M | 555.19M |
|
|
|||||
